A healthcare professional prepares a dose of AstraZeneca (COVID-19) vaccine at the Narok County Referral Hospital, in Narok, Kenya. [Reuters]
The relatively short shelf life of AstraZeneca Plc's (AZN.L) COVID-19 vaccine is complicating the rollout to the world's poorest nations, according to officials and internal World Health Organization documents reviewed by Reuters.